Phibro Animal Health | PAHC - Attività Correnti





Attività Correnti Cambiamento Data
Align Technology USD 2.73B 63.03M 2026-09
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 393.45M 4M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Canopy Growth CAD 506.36M 23.1M 2026-06
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Henry Schein USD 4.6B 104M 2026-06
Idexx Laboratories USD 1.51B 55.41M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Pacira USD 615.21M 100.25M 2026-06
Phibro Animal Health USD 935.51M 41.44M 2026-06
Prestige Brands USD 496.81M 65.33M 2026-06
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
Zoetis USD 6.36B 118M 2026-06